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Abstract
This editorial represents a plea to retrovirologists to attend the XVI International Conference on
AIDS that will take place in Toronto, Canada between August 13–18, 2006. In short, it is vital that
politicians and opinion leaders understand that basic scientists are no less committed to the
worldwide battle against HIV than community activists or non-basic scientists, and the best way to
demonstrate this is by showing up.
The XVIth International Conference on AIDS will take
place in Toronto, Canada between Aug. 13–18, 2006. It is
vital that this meeting be attended by basic retrovirolo-
gists working in the field of HIV as well as by clinicians,
epidemiologists and social scientists concerned with pre-
ventive and other aspects of HIV research. The reasons for
this are simple. The International Conference on AIDS is
the most media-intensive event in the world in regard to
dissemination of information about the HIV epidemic. In
addition, the International Conference on AIDS is the
only one of its type that attempts to bring together scien-
tists working on all aspects of the HIV epidemic together
with members of industry, community representatives,
and their supporters. As such, this is probably the only
conference in the world that attempts to appeal to a broad
spectrum of attendees and, in a sense, attempts to be "all
things to all people". Although such a lofty objective can
never be completely achieved, the efforts involved in try-
ing are both noble and worthwhile.
Quite simply, the International Conference on AIDS
probably does more to promote HIV awareness and edu-
cation throughout the world than any other conference or
group of scientific papers can currently achieve. In order
to sustain this level of interest and support, it is vital that
the conference attracts a critical mass of compelling
papers that can articulate hope for the future in regard to
an improved understanding of the HIV replication cycle,
development of novel targets for drug development, and
more appropriate use of both current and future drugs in
a therapeutic setting. Moreover, these considerations
apply as much in the context of developing countries as
they do in countries such as the United States, Canada,
and the nations of Western Europe. For example, it will be
important to discuss the initial results of the PEPFAR pro-
gram of the US government for purchase and distribution
of antiretroviral drugs in Africa, which currently reaches at
least 400,000 people. The latter is by far the most gener-
ous program of its type in the world and it is appropriate
that the Conference make it a focal point in regard to
expanded access to these life-saving drugs.
Scientists throughout the world who work on HIV should
consider it their obligation to submit abstracts to the
International Conference and to attend. We, who work in
this field, have been the beneficiaries of major grant sup-
port as a result of increased levels of funding that are now
available in the field. These increased levels of funding
have come about, in part, because of political pressure
brought to bear by community groups who have lobbied
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for the accomplishment of research that will make a dif-
ference. In addition, there are obvious political and eco-
nomic factors that have also resulted in increased levels of
funding in recent years. Major philanthropic organiza-
tions, such as the Gates and Soros Foundations, etc have
also channeled more money into HIV research because of
the global catastrophic situation.
Against this background, it is important that all scientists
show solidarity in regard to the HIV crisis. It is not suffi-
cient for any of us to want to work on problems that relate
to the ideas in our grant applications without considering
the global dimensions of the pandemic at the same time.
The Toronto Conference organizers hope that we will
attract a large number of first-rate abstracts that will make
ours a first-rate scientific conference. Of course, we also
want to organize a conference that will result in antiretro-
viral drugs becoming available to the millions of people
around the world who are so desperately at need. Basic
scientists as well as others in the field can vote with their
feet by coming to Toronto and ensuring that the Confer-
ence is a major success.
All of this recognizes that basic scientists often derive
more direct benefit by attending specialized meetings. The
International Conferences on AIDS cannot compete in
this regard. Nevertheless, it seems also important for basic
scientists to interact with other disciplines and to meet
industry as well as community representatives. The Inter-
national Conference on AIDS provides the best podium
for this.
We look forward to welcoming the readers of Retrovirology
to Toronto for what will be a stimulating and challenging
conference that will provide specific information to those
who attend specialty sessions as well as more general
information to those who want to learn how they person-
ally can play a role in the global fight against HIV/AIDS.